Biowaiver only for BCS I and – under certain conditions – BCS III drugs [Dissolution / BCS / IVIVC]

posted by Helmut Homepage – Vienna, Austria, 2020-07-16 11:27 (802 d 12:22 ago) – Posting: # 21710
Views: 2,266

Hi Steven,

THX! I was not aware of this one (should have searched my own guideline collection).

» https://www.ema.europa.eu/en/rivaroxaban-product-specific-bioequivalence-guidance

@dshah

BCS Classification  BCS Class: ☐ I  ☐ III   Neither of the two
                    Background: rivaroxaban may be considered a low solubility compound.

… is the end of the story.

Dif-tor heh smusma 🖖 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
22,390 posts in 4,685 threads, 1,594 registered users;
online 6 (0 registered, 6 guests [including 3 identified bots]).
Forum time: Monday 23:49 CEST (Europe/Vienna)

The purpose of models is not to fit the data,
but to sharpen the questions.    Samuel Karlin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5